Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine
- PMID: 7582281
- DOI: 10.1164/ajrccm.152.5.7582281
Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine
Abstract
Regular treatment with salbutamol increases airway responsiveness to allergen but not to methacholine and produces tolerance to the bronchoprotective effect of salbutamol. The current study addresses the effect of inhaled corticosteroid on these aspects of regular beta 2 agonist use. A group of 13 atopic asthmatic subjects free from all asthma medications and remote from allergen exposure were studied. We used a double-blind, random-order, crossover study to compare four 1-wk treatment periods with > or = 1 wk washout: placebo, salbutamol, 200 micrograms four times per day, budesonide, 400 micrograms four times per day, and the combination of salbutamol and budesonide. We measured the methacholine PC20 and the methacholine dose shift produced acutely by 200 micrograms salbutamol after 7 d and the allergen PC15 after 8 d treatment. Blinded medications were withheld for 8 to 10 h before measurements. The methacholine PC20 was not affected by regular salbutamol but increased significantly (p < 0.014) after both budesonide-containing regimens. Neither the dose shift nor its significant reduction by regularly used beta 2 agonist were influenced by the inhaled corticosteroid. The four allergen PC15 values were significantly different from each other. Compared with placebo, the allergen PC15 was 0.6 doubling doses lower after salbutamol (p = 0.021) and 1.3 doubling doses higher after budesonide (p < 0.001); the allergen PC15 was reduced by 0.53 doubling doses from this new baseline (p = 0.039) when salbutamol and budesonide were used together.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1603-7. doi: 10.1164/ajrccm.154.6.8970342. Am J Respir Crit Care Med. 1996. PMID: 8970342 Clinical Trial.
-
Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.Am J Respir Crit Care Med. 1996 Jan;153(1):70-5. doi: 10.1164/ajrccm.153.1.8542165. Am J Respir Crit Care Med. 1996. PMID: 8542165 Clinical Trial.
-
Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.Chest. 1996 Apr;109(4):953-6. doi: 10.1378/chest.109.4.953. Chest. 1996. PMID: 8635376 Clinical Trial.
-
Inhaled beta2-agonists and airway responses to allergen.J Allergy Clin Immunol. 1998 Nov;102(5):S96-9. doi: 10.1016/s0091-6749(98)70038-7. J Allergy Clin Immunol. 1998. PMID: 9819316 Review.
-
The effect of theophylline and beta 2 agonists on airway reactivity.Chest. 1987 Jul;92(1 Suppl):15S-21S. Chest. 1987. PMID: 2885155 Review.
Cited by
-
Beta2-agonists for asthma: the pediatric perspective.Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):209-18. doi: 10.1385/CRIAI:31:2:209. Clin Rev Allergy Immunol. 2006. PMID: 17085794 Review.
-
Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.Drugs. 2000 Nov;60(5):1141-78. doi: 10.2165/00003495-200060050-00010. Drugs. 2000. PMID: 11129126 Review.
-
Antagonism of long-acting beta2-adrenoceptor agonism.Br J Clin Pharmacol. 2002 Sep;54(3):231-45. doi: 10.1046/j.1365-2125.2002.01651.x. Br J Clin Pharmacol. 2002. PMID: 12236842 Free PMC article. Review.
-
Methacholine bronchial provocation test in patients with asthma: serial measurements and clinical significance.Korean J Intern Med. 2018 Jul;33(4):807-814. doi: 10.3904/kjim.2017.043. Epub 2018 Jan 17. Korean J Intern Med. 2018. PMID: 29334723 Free PMC article.
-
Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma.Thorax. 1999 Jun;54(6):488-92. doi: 10.1136/thx.54.6.488. Thorax. 1999. PMID: 10335001 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources